Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Crown BioScience
Crown BioScience
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
JSR Life Sciences companies form Japanese joint venture
Based in Tokyo, the venture will establish a local team led by an experienced General Manager, Hiroki Itou
Research & Development
Crown Bioscience opens oncology biomarker R&D centre in California
New custom-designed 32,000 sqft facility in San Diego to support the growth of both oncology biomarker and inflammation service portfolios
Research & Development
Crown Bioscience and Charles River agree to expand access to ZDSD rat model
The agreement enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome
Research & Development
Crown Bioscience creates Center of Excellence for bioinformatics, big data and biomarker discovery
Services and capacity increase with new site opening
Research & Development
Crown Bioscience expands cardiovascular and metabolic disease research capability
The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
Research & Development
CrownBio expands humanised models for targeted immunotherapy
The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models
Research & Development
Grant awarded to doctors researching innovative PDX models in immuno-oncology
Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create breakthroughs in preclinical oncology strategies
Subscribe now